The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews

Cited by (1,000)

Items 501–600 of 1,000

  1. Parallel changes in serotonin levels in brain and blood following acute administration of MDMA
    Cheryl M Collins, Joris Kloek, J. Martin Elliott · 2012 · Journal of Psychopharmacology
  2. Validated liquid chromatographic–electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma
    Melanie Mueller, Frank T. Peters, George A. Ricaurte, Hans H. Maurer · 2007 · Journal of Chromatography B
  3. MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females
    Julie Koenig, Christine Lazarus, Hélène Jeltsch‐David, Sami Ben Hamida, Céline Riegert, Christian R. Kelche, B JONES, Jean‐Christophe Cassel · 2005 · Pharmacology Biochemistry and Behavior
  4. Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters
    Christian Pifl, Gábor Nagy, Sándor Berényi, Alexandra Kattinger, Harald Reither, Sándor Antus · 2005 · Journal of Pharmacology and Experimental Therapeutics
  5. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment
    Doyle, Marcus A., Ling, Susan, Lui, Leanna M.W., Fragnelli, Paul, Teopiz, Kayla M., Ho, Roger, Di Vincenzo, Joshua D., Rosenblat, Joshua D., Gillissie, Emily S., Nogo, Danica et al. · 2022 · Expert Opinion on Drug Safety
  6. In Vitro Screening of Psychoactive Drugs by [35S]GTP.GAMMA.S Binding in Rat Brain Membranes
    Nonaka, Ryouichi, Nagai, Fumiko, Ogata, Akio, Satoh, Kanako · 2007 · Biological and Pharmaceutical Bulletin
  7. Effects of adenosine A2a receptor agonist and antagonist on hippocampal nuclear factor-kB expression preceded by MDMA toxicity
    Fatemeh Kermanian, Mansooreh Soleimani, Alireza Ebrahimzadeh‐Bideskan, Hossein Haghir, Mehdi Mehdizadeh · 2012 · Metabolic Brain Disease
  8. The combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice
    Andrés Ciudad‐Roberts, Leticia Duart-Castells, Jorge Camarasa, David Pubill, Elena Escubedo · 2015 · Toxicology and Applied Pharmacology
  9. Dissecting neural mechanisms of prosocial behaviors
    Jessica J. Walsh, Daniel J. Christoffel, Xiaoting Wu, Matthew B. Pomrenze, Robert C. Malenka · 2020 · Current Opinion in Neurobiology
  10. Role of the gut–brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress
    Youge Qu, Akifumi Eguchi, Li Ma, Xiayun Wan, Chisato Mori, Kenji Hashimoto · 2023 · Neurobiology of Disease
  11. Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3receptors and BDNF in place preference acquisition
    Andrés Ciudad‐Roberts, Jorge Camarasa, Carlos J. Ciudad, David Pubill, Elena Escubedo · 2015 · British Journal of Pharmacology
  12. Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus
    Kyung‐Ok Cho, Gyu‐Seek Rhee, Seung Jun Kwack, S.Y. Chung, Seong-Yun Kim · 2008 · Neuroscience
  13. Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes
    Helena Pontes, Carla Sousa, Renata Silva, Eduarda G. R. Fernandes, Helena Carmo, Fernando Remião, Félix Dias Carvalho, Maria de Lourdes Bastos · 2008 · Toxicology
  14. Neuroimaging in Human MDMA (Ecstasy) Users
    Ronald L. Cowan, Deanne M. Roberts, James M. Joers · 2008 · Annals of the New York Academy of Sciences
  15. Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans
    Melanie Mueller, Erin A Kolbrich, Frank T. Peters, Hans H. Maurer, Una D. McCann, Marilyn Ann Huestis, George A. Ricaurte · 2009 · Therapeutic Drug Monitoring
  16. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in the rat frontal cortex but not in the hippocampus
    Ana García‐Osta, Joaquı́n Del Rı́o, Diana Frechilla · 2004 · Molecular Brain Research
  17. Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA
    Sami Ben Hamida, Antoine Tracqui, Anne Pereira de Vasconcelos, Esther Szwarc, Christine Lazarus, Christian R. Kelche, Byron C. Jones, Jean‐Christophe Cassel · 2008 · The International Journal of Neuropsychopharmacology
  18. Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats
    Tomáš Páleníček, Marie Balı́ková, Miroslava Rohanová, Tomáš Novák, Jiřı́ Horáček, Michaela Fujáková, Cyril Höschl · 2010 · Pharmacology Biochemistry and Behavior
  19. A novel MDMA analogue, UWA‐101, that lacks psychoactivity and cytotoxicity, enhances l ‐DOPA benefit in parkinsonian primates
    Tom H. Johnston, Zak A. Millar, Philippe Huot, Keith Wagg, Sherri L. Thiele, Danielle Salomonczyk, C. J. Yong-Kee, Michael N. Gandy, Matthew J. McIldowie, Katie D. Lewis et al. · 2012 · The FASEB Journal
  20. Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration
    Pier Francesca Porceddu, Ismail Ogunbayode Ishola, Liliana Contu, Micaela Morelli · 2016 · Neurotoxicity Research
  21. Locomotor and pyretic effects of MDMA–ethanol associations in rats
    Jean‐Christophe Cassel, Hélène Jeltsch‐David, Julie Koenig, Byron C. Jones · 2004 · Alcohol
  22. A PET study of effects of chronic 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) on serotonin markers in Göttingen minipig brain
    Paul D. Cumming, Mette Møller, Kjeld Benda, Luciano Minuzzi, Steen Jakobsen, Svend Borup Jensen, Bente Pakkenberg, Anette Kirstine Stark, Jan Bert Gramsbergen, Mette Findal Andreasen et al. · 2007 · Synapse
  23. High concentrations of MDMA (‘ecstasy’) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells
    Laura Hondebrink, Jan Meulenbelt, Marieke Meijer, Martin van den Berg, Remco H.S. Westerink · 2011 · Neuropharmacology
  24. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats
    Erica Shen, Syed F. Ali, Jerrold S. Meyer · 2011 · Neuropharmacology
  25. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine (“Ecstasy”)/polydrug users
    Adrian Burgess, Louise Venables, Helena Jones, Rhiannon G. Edwards, Andrew C. Parrott · 2011 · Psychopharmacology
  26. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage
    Giulia Costa, Micaela Morelli, Nicola Simola · 2017 · Neurotoxicity Research
  27. Gas chromatography–ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine
    Daniel Gomes, Paula Guedes de Pinho, Helena Pontes, Luísa Maria Ferreira, Paula S. Branco, Fernando Remião, Félix Dias Carvalho, Maria de Lourdes Bastos, Helena Carmo · 2010 · Journal of Chromatography B
  28. Investigating the Role of Serotonin in Visual Orientation Processing Using an ‘Ecstasy’ (MDMA)-Based Research Model
    Clare Dickson, Raimondo Bruno, John Brown · 2009 · Neuropsychobiology
  29. A mechanistic insight into 3,4-methylenedioxymethamphetamine (“ecstasy”)-mediated hepatotoxicity
    Irene Antolino-Lobo, Jan Meulenbelt, Martin van den Berg, Majorie B.M. van Duursen · 2011 · Veterinary Quarterly
  30. Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats
    Eszter Kirilly, Anita Benkő, Linda Ferrington, Rómeó D. Andó, Paul A. T. Kelly, György Bagdy · 2005 · The International Journal of Neuropsychopharmacology
  31. Studies of (±)-3,4-Methylenedioxymethamphetamine (MDMA) Metabolism and Disposition in Rats and Mice: Relationship to Neuroprotection and Neurotoxicity Profile
    Melanie Mueller, Concepción Maldonado Adrián, Jie Yuan, Una D. McCann, George A. Ricaurte · 2012 · Journal of Pharmacology and Experimental Therapeutics
  32. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
    Anna Maria Górska, Katarzyna Kamińska, Agnieszka Wawrzczak‐Bargieła, Giulia Costa, Micaela Morelli, Ryszard Przewłocki, Grzegorz Kreiner, Krystyna Gołembiowska · 2017 · Neurotoxicity Research
  33. Bioanalytical methods for determining ecstasy components in biological matrices: A review
    Anny Talita M. da Silva, Carliani Dal Piero Betzel Bessa, Warley de Souza Borges, Keyller Bastos Borges · 2018 · TrAC Trends in Analytical Chemistry
  34. Mice with Decreased Cerebral Dopamine Function following a Neurotoxic Dose of MDMA (3,4-Methylenedioxymethamphetamine, “Ecstasy”) Exhibit Increased Ethanol Consumption and Preference
    María Izco, Ivanny Marchant, Isabel Escobedo, Inés Peraile, Mercedes Delgado, Alejandro Higuera‐Matas, Óscar Olías, Emilio Ambrosio, Esther O’Shea, M. Isabel Colado · 2007 · Journal of Pharmacology and Experimental Therapeutics
  35. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats
    Thompson, Murray R., Callaghan, Paul D., Hunt, Glenn E., McGregor, Iain S. · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  36. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: a role for handling and oxytocin receptors
    Ramos, Linnet, Hicks, Callum, Caminer, Alex, Couto, Kalliu, Narlawar, Rajeshwar, Kassiou, Michael, McGregor, Iain S. · 2016 · Pharmacology Biochemistry and Behavior
  37. Vesicular Monoamine Transporter 2 and the Acute and Long-Term Response to 3,4-(±)-Methylenedioxymethamphetamine
    Lucina E. Lizarraga, Aram B. Cholanians, Andy V. Phan, Joseph M. Herndon, Serrine S. Lau, Terrence J. Monks · 2014 · Toxicological Sciences
  38. Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
    Madeline Marie Pantoni, Stephan Anagnostaras · 2019 · Pharmacological Reviews
  39. Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut–microbiota–brain axis
    Youge Qu, Akifumi Eguchi, Xiayun Wan, Li Ma, Lijia Chang, Jiajing Shan, Yong Hua Yang, Chisato Mori, Kenji Hashimoto · 2022 · Psychiatry Research
  40. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex
    Sunila G Nair, Gary A. Gudelsky · 2006 · Brain Research Bulletin
  41. Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use
    Stanley C. Flavel, Jason M. White, Gabrielle Todd · 2012 · Journal of Applied Physiology
  42. Prior MDMA (Ecstasy) use is associated with increased basal ganglia–thalamocortical circuit activation during motor task performance in humans: An fMRI study
    John Karageorgiou, Mary S. Dietrich, Evonne J. Charboneau, Neil D. Woodward, Jennifer Urbano Blackford, Ronald M. Salomon, Ronald L. Cowan · 2009 · NeuroImage
  43. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder
    Timothy Amoroso · 2015 · Journal of Psychoactive Drugs
  44. Comparative effects of amphetamine-like psychostimulants on rat hippocampal cell genesis at different developmental ages
    Rubén García‐Cabrerizo, María Julia García-Fuster · 2016 · NeuroToxicology
  45. Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.
    Ross van de Wetering, Susan Schenk · 2017 · Psychopharmacology
  46. MDMA modifies active avoidance learning and recall in mice
    José Manuel Trigo, Araceli Cabrero-Castel, Fernando Berrendero, Rafael J. Maldonado, Patricia Robledo · 2008 · Psychopharmacology
  47. Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology
    Glenn Dumont, Cornelis Kramers, FCGJ Sweep, Jacques J. Willemsen, Daan Johannes Touw, Rik C. Schoemaker, JMA van Gerven, Jan K. Buitelaar, Robbert‐Jan Verkes · 2008 · Journal of Psychopharmacology
  48. Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days
    Eszter Kirilly, Eszter Molnár, Brigitta Balogh, Sándor Kántor, Stefan Rocco Hansson, Miklós Palkovits, György Bagdy · 2008 · The International Journal of Neuropsychopharmacology
  49. Human Ecstasy Use is Associated with Increased Cortical Excitability: An fMRI Study
    Amy L. Bauernfeind, Mary S. Dietrich, Jennifer Urbano Blackford, Evonne J. Charboneau, James G Lillevig, Christopher J. Cannistraci, Neil D. Woodward, Aize Cao, Tristan J. Watkins, Christina Iorio et al. · 2011 · Neuropsychopharmacology
  50. Brain temperature: from physiology and pharmacology to neuropathology
    Eugene A. Kiyatkin · 2018 · Handbook of clinical neurology
  51. On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg
    Elena Puerta, Isabel Hervías, Norberto Aguirre · 2009 · Neuropsychobiology
  52. Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat
    Csaba Ádori, Péter Lőw, Rómeó D. Andó, Lise Gutknecht, Dorottya Pap, Ferencné Truszka, József Takács, Gábor Géza Kovács, Klaus‐Peter Lesch, György Bagdy · 2010 · Psychopharmacology
  53. Blue–yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users
    Lea M. Hulka, Michael Wagner, Katrin H. Preller, Daniela Jenni, Boris B. Quednow · 2012 · The International Journal of Neuropsychopharmacology
  54. Effects of ethanol and ecstasy on conditioned place preference in the rat
    Bc Jones, Sami Ben Hamida, Anne Pereira de Vasconcelos, Christian R. Kelche, Christine Lazarus, Rolf Jackisch, Jean‐Christophe Cassel · 2009 · Journal of Psychopharmacology
  55. Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure
    Francesca Felicia Caputi, Martina Palmisano, Lucia Carboni, Sanzio Candeletti, Patrizia Romualdi · 2016 · Pharmacological Research
  56. Decision‐making in chronic ecstasy users: a systematic review
    F. Betzler, Leonard Viohl, N. Romanczuk-Seiferth · 2017 · European Journal of Neuroscience
  57. Experimental Studies on the Role(s) of Serotonin in Learning and Memory Functions
    Jean‐Christophe Cassel · 2010 · Handbook of behavioral neuroscience
  58. Chronic MDMA induces neurochemical changes in the hippocampus of adolescent and young adult rats: Down-regulation of apoptotic markers
    Rubén García‐Cabrerizo, María Julia García-Fuster · 2015 · NeuroToxicology
  59. Age-dependent (+)MDMA-mediated Neurotoxicity in Mice
    Maria Elena Reveron, Terrence J. Monks, Christine L. Duvauchelle · 2005 · NeuroToxicology
  60. Psychiatric Disorders and Their Correlates Among Young Adult MDMA Users in Ohio
    Rüssel S. Falck, Robert Gideon Carlson, Jichuan Wang, Harvey Alan Siegal · 2006 · Journal of Psychoactive Drugs
  61. Ethanol–MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination
    Sami Ben Hamida, Erin Plute, Sonia Bach, Christine Lazarus, Antoine Tracqui, Christian R. Kelche, Anne Pereira de Vasconcelos, Byron C. Jones, Jean‐Christophe Cassel · 2007 · Psychopharmacology
  62. Is There a Connection?
    Oliver R. Segal, David E. Ward · 2008 · Journal of Cardiovascular Electrophysiology
  63. Effects of MDMA on blood glucose levels and brain glucose metabolism
    María Luisa Soto‐Montenegro, Juan José Vaquero, Celso Arango, George A. Ricaurte, Pedro Garcia-Barreno, Manuel Desco · 2007 · European Journal of Nuclear Medicine and Molecular Imaging
  64. Med-Psych Drug–Drug Interactions Update
    Scott C. Armstrong, Kelly L. Cozza, David M. Benedek · 2002 · Psychosomatics
  65. MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press
    A. Richard Green · 2004 · Psychopharmacology
  66. Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPγS binding in adult rats
    Cynthia A. Crawford, Michael T. Williams, Jodi Lynn Kohutek, Fiona Choi, Shelly T. Yoshida, Sanders A. McDougall, Charles V. Vorhees · 2006 · Brain Research
  67. Assessment of Chronic Exposure to MDMA in a Group of Consumers by Segmental Hair Analysis
    Simona Pichini, Sandra Poudevida, Mitona Pujadas, Ester Menoyo, Roberta Pacifici, Magı́ Farré, Rafael de la Torre · 2006 · Therapeutic Drug Monitoring
  68. A Study on Photostability of Amphetamines and Ketamine in Hair Irradiated under Artificial Sunlight
    Giorgia Miolo, Marianna Tucci, Luca Menilli, Giulia Stocchero, Susanna Vogliardi, Salvatore Scrivano, Massimo Montisci, Donata Favretto · 2018 · Brain Sciences
  69. Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats
    Rui Tao, Ibrahim M. Shokry, John J. Callanan, H. Daniel Adams, Zhiyuan Ma · 2014 · Psychopharmacology
  70. The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine (“ecstasy”): A concurrent microdialysis and plasma analysis study
    Kevin Sean Murnane, Heather L. Kimmel, Kenner C. Rice, LL Howell · 2011 · Hormones and Behavior
  71. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain
    Céline Riegert, Franziska Wedekind, Sami Ben Hamida, Susanne Rutz, Anna Katharina Rothmaier, Byron C. Jones, Jean‐Christophe Cassel, Rolf Jackisch · 2008 · The International Journal of Neuropsychopharmacology
  72. MDMA (ecstasy) delays pubertal development and alters sperm quality after developmental exposure in the rat
    Marta Barenys, Jesús Gómez-Catalán, Lydia Camps, Elisabet Teixidó, Joaquín de Lapuente, Javier González-Linares, Joan Serret, Miquel Borràs, Miquel Rodamilans, J.M. Llobet · 2010 · Toxicology Letters
  73. Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs
    A. Richard Green, Kathryn S. Saadat, J. Martin Elliott, María Isabel Colado · 2004 · Psychopharmacology
  74. Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats
    María Ramos, Beatriz Goñi‐Allo, Norberto Aguirre · 2005 · Behavioural Brain Research
  75. Minoxidil prevents 3,4‐methylenedioxymethamphetamine‐induced serotonin depletions: role of mitochondrial ATP‐sensitive potassium channels, Akt and ERK
    Beatriz Goñi‐Allo, Elena Puerta, María Ramos, Berta Lasheras, Joaquı́n Jordán, Norberto Aguirre · 2007 · Journal of Neurochemistry
  76. MDMA‐evoked changes in cerebral blood flow in living porcine brain: Correlation with hyperthermia
    Pedro Rosa‐Neto, Aage Kristian Olsen Alstrup, ALBERT H. GJEDDE, Hideaki Watanabe, Paul D. Cumming · 2004 · Synapse
  77. Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish
    Luisa Ponzoni, Mariaelvina Sala, Daniela Braida · 2016 · Behavioural Brain Research
  78. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats
    Beatriz Goñi‐Allo, Elena Puerta, Brian Ó. Mathúna, Isabel Hervías, Berta Lasheras, Rafael de la Torre, Norberto Aguirre · 2008 · Neuropharmacology
  79. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats
    Brian J. Piper, Syed F. Ali, Lauren G. Daniels, Jerrold S. Meyer · 2010 · Synapse
  80. Involvement of Nicotinic Receptors in Methamphetamine- and Mdma-Induced Neurotoxicity
    Elena Escubedo, Jorge Camarasa, Carlos Chipana, Sara Garcia‐Ratés, David Pubill · 2009 · International review of neurobiology
  81. MDMA and Metabolite Disposition in Expectorated Oral Fluid After Controlled Oral MDMA Administration
    Allan J. Barnes, Karl B. Scheidweiler, Erin A Kolbrich, David A. Gorelick, Robert S. Goodwin, Marilyn Ann Huestis · 2011 · Therapeutic Drug Monitoring
  82. Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits
    Sònia Abad, Jorge Camarasa, David Pubill, Antoni Camins, Elena Escubedo · 2015 · Molecular Neurobiology
  83. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age
    Giulia Costa, Pier Francesca Porceddu, Marcello Serra, Maria Antonietta Casu, Valentina Schiano, Francesco Napolitano, Annalisa Pinna, Alessandro Usiello, Micaela Morelli · 2019 · International Journal of Molecular Sciences
  84. Developmental neurotoxicity of MDMA. A systematic literature review summarized in a putative adverse outcome pathway
    Marta Barenys, Ingrid Reverte, Stefan Masjosthusmann, Jesús Gómez-Catalán, Ellen Fritsche · 2019 · NeuroToxicology
  85. “Addicted to Euphoria”
    Jenny Bearn, Matthew O'Brien · 2015 · International review of neurobiology
  86. A long hangover from party drugs: Residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination
    Petra S. Van Nieuwenhuijzen, Mohammed Abul Kashem, Izuru Matsumoto, Glenn E. Hunt, Iain S. McGregor · 2010 · Neurochemistry International
  87. Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users
    Ronald L. Cowan, Nicolas R. Bolo, Mary S. Dietrich, Erica Haga, Scott E. Lukas, Perry Franklin Renshaw · 2007 · Psychiatry Research Neuroimaging
  88. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions
    Beatriz Goñi‐Allo, Mar�a Ramos, Isabel Herv'as, Berta Lasheras, Norberto Aguirre · 2006 · Journal of Psychopharmacology
  89. MDMA attenuates THC withdrawal syndrome in mice
    Clara Touriño, Rafael J. Maldonado, Olga Valverde · 2007 · Psychopharmacology
  90. Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms
    Fonseca, Diogo A., Ribeiro, Daniel M., Tapadas, Margarida, Cotrim, Maria Dulce · 2021 · European Journal of Pharmacology
  91. Yohimbine reinstates extinguished 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats with prior exposure to chronic yohimbine
    Kevin T. Ball, Hanna Jarsocrak, Johanna Hyacinthe, Justina L. Lambert, James Lockowitz, Jordan Schrock · 2015 · Behavioural Brain Research
  92. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue
    Julie A. Marusich, Kateland R. Antonazzo, Bruce E. Blough, Simon D. Brandt, Pierce V. Kavanagh, John S. Partilla, Michael H. Baumann · 2015 · Neuropharmacology
  93. Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice
    Clara Ros‐Simó, Jéssica Ruiz‐Medina, Olga Valverde · 2011 · Psychopharmacology
  94. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization
    Akihiro Mouri, Yukihiro Noda, Minae Niwa, Yurie Matsumoto, Takayoshi Mamiya, Atsumi Nitta, Kiyofumi Yamada, Shoei Furukawa, Tatsunori Iwamura, Toshitaka Nabeshima · 2017 · Behavioural Brain Research
  95. MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity
    Ronald M. Salomon, John Karageorgiou, Mary S. Dietrich, Jessica Y. McLellan, Evonne J. Charboneau, Jennifer Urbano Blackford, Ronald L. Cowan · 2011 · Drug and Alcohol Dependence
  96. Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA (‘ecstasy’)
    Natacha Vanattou‐Saïfoudine, Ruth McNamara, Andrew Harkin · 2010 · Psychopharmacology
  97. Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice
    Alena Máchalová, Karel Šlais, Dagmar Vršková, Alexandra Šulcová · 2012 · Pharmacology Biochemistry and Behavior
  98. Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells
    Rokhsareh Meamar, Fereshteh Karamali, M. Hamid, Mahmoud Etebari, Mohammad Hossein Nasr‐Esfahani, Hossein Baharvand · 2010 · Toxicology in Vitro
  99. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity
    Elena Escubedo, Sònia Abad, I. Torres, Jorge Camarasa, David Pubill · 2010 · Neurochemistry International
  100. Reduced 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Initiated Oxidative DNA Damage and Neurodegeneration in Prostaglandin H Synthase-1 Knockout Mice
    Winnie Jeng, Peter G. Wells · 2010 · ACS Chemical Neuroscience